Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells

2018

Background The mechanism of action of oral cladribine, recently licensed for relapsing multiple sclerosis, is unknown.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

39

References

67

Citations